Karolinska Development (publ.) Interim report January - September 2010
(Thomson Reuters ONE) -
STOCKHOLM - Sweden, November 11, 2010. Karolinska Development AB announces
publication of its Interim report, January-September 2010; the full report is
available on the company's website.
Group
January - September 2010
* Investments in portfolio companies, including subsidiaries and associates,
during the period amounted to SEK 143.6m (145.2)
* Cash flow during the period amounted to SEK -182.6m (-117.5)
* The value of the total portfolio according to the International Private
Equity and Venture Capital Valuation Board guidelines, including
subsidiaries, associates and other financial investments, has at September
30, 2010 been calculated at SEK 1 556.6m compared to SEK 1 512.3m as of
December 31, 2009
* Net asset value per share amounted to SEK 58,60 (62,70 as of December
31, 2009)
* Revenue amounted to SEK 11.5m (23.4)
* Profit / loss for the period amounted to SEK -114.9m (16.7)
* Earnings / loss per share before dilution amounted to SEK -3,46 (0,62)
Third quarter July - September 2010
* Investments in portfolio companies during the period amounted to SEK 55.7m
(44.9)
* Cash flow during the period amounted to SEK -80.1m (-47.7)
* Revenue amounted to SEK 3.1m (9.4)
* Profit / loss for the period amounted to SEK -15.3m (63.2)
* Earnings / loss per share before dilution amounted to SEK -0,22 (2,34)
Significant events third quarter 2010
* Karolinska Development announced the appointment of Mr. Torbjörn Bjerke as
new CEO of the company in August. The position will be assumed in the fall
of 2010. Mr. Conny Bogentoft will assume the position of Chief Scientific
Officer of Karolinska Development.
Parent Company
January - September 2010
* Revenue amounted to SEK 8.2m (5.8)
* Operating loss amounted to SEK -95.3m (-75.0)
* Investments in subsidiaries during the period amounted to SEK 43.1m and in
associates and other financial investments to SEK 100.5m
For further information, please contact:
Gunnar Casserstedt CFO, Phone: +46 73 068 37 00
gunnar.casserstedt(at)karolinskadevelopment.com
Conny Bogentoft CEO, Phone: +46 70 668 61 43
conny.bogentoft(at)karolinskadevelopment.com
Note
Karolinska Development AB publ. discloses the information provided herein
pursuant to the NASDAQ OMX Stockholm rules for issuers. The information was
provided for public release on November 11, 2010, at 12:00 CET. This report has
been prepared in both Swedish and English. In the event of any discrepancy in
the content of the two versions, the Swedish version shall take precedence.
TO THE EDITORS
About Karolinska Development
Karolinska Development manages one of the largest portfolios of life science
companies in Europe. Using a unique business model, the company cost efficiently
guides the commercialization of world class life science innovations. Since its
inception in 2003, Karolinska Development has built a portfolio of some 40
companies. Among the company's projects, 12 candidate drugs are undergoing
clinical trials and it is estimated that more than 20 substances have first-in-
class potential. www.karolinskadevelopment.com
[HUG#1461423]
Interim report Q3:
http://hugin.info/143071/R/1461423/400630.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Karolinska Development AB (publ) via Thomson Reuters ONE
Unternehmensinformation / Kurzprofil:
Datum: 11.11.2010 - 12:01 Uhr
Sprache: Deutsch
News-ID 48677
Anzahl Zeichen: 4320
contact information:
Town:
Solna
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 190 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Karolinska Development (publ.) Interim report January - September 2010"
steht unter der journalistisch-redaktionellen Verantwortung von
Karolinska Development AB (publ) (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
